Laura H. Porter

Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer

Matthew J. Watt, Ashlee K. Clark, Luke A. Selth et al. · Science Translational Medicine · 2019 · 314 citations

Medicine, Oncology, Urology +13

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Mitchell G. Lawrence, Daisuke Obinata, Shahneen Sandhu et al. · European Urology · 2018 · 119 citations · Full text

Medicine, Oncology, Urology +14

The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer

Richard J. Rebello, Eric Kusnadi, Donald P. Cameron et al. · Clinical Cancer Research · 2016 · 74 citations

Medicine, Oncology, Pharmacology +17

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology

Gail P. Risbridger, Ashlee K. Clark, Laura H. Porter et al. · Nature Communications · 2021 · 70 citations · Full text

Medicine, Oncology, Urology +12

Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate‐tolerant cells

Laura H. Porter, Kohei Hashimoto, Mitchell G. Lawrence et al. · British Journal of Urology · 2017 · 51 citations · Full text

Medicine, Oncology, Pathology +17